Linked Life Data

10831354

Source:http://linkedlifedata.com/resource/pubmed/id/10831354

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2000-7-6
pubmed:abstractText
A phase II study of Mifepristone (RU486) was conducted in patients with ovarian cancer whose tumors were resistant to cisplatin and paclitaxel, alone or in combination. Patients and
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0090-8258
pubmed:author
pubmed:copyrightInfo
Copyright 2000 Academic Press.
pubmed:issnType
Print
pubmed:volume
77
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
429-32
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Phase II study of mifepristone (RU486) in refractory ovarian cancer.
pubmed:affiliation
Division of Gynecologic Oncology, UMDNJ/Robert Wood Johnson Medical School at Camden, Camden, New Jersey 08103, USA. Rocereto-Thomas@CooperHealth.edu
pubmed:publicationType
Journal Article, Clinical Trial, Clinical Trial, Phase II